BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29223498)

  • 1. Heparin-fibronectin interactions in the development of extracellular matrix insolubility.
    Raitman I; Huang ML; Williams SA; Friedman B; Godula K; Schwarzbauer JE
    Matrix Biol; 2018 Apr; 67():107-122. PubMed ID: 29223498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleation of fibronectin fibril assembly requires binding between heparin and the 13th type III module of fibronectin.
    Lovett BM; Hill KE; Randolph EM; Wang L; Schwarzbauer JE
    J Biol Chem; 2023 May; 299(5):104622. PubMed ID: 36933809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparan sulfate is necessary for the early formation of nascent fibronectin and collagen I fibrils at matrix assembly sites.
    Hill KE; Lovett BM; Schwarzbauer JE
    J Biol Chem; 2022 Jan; 298(1):101479. PubMed ID: 34890641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin matrix as a scaffold for procollagen proteinase binding and collagen processing.
    Saunders JT; Schwarzbauer JE
    Mol Biol Cell; 2019 Aug; 30(17):2218-2226. PubMed ID: 31242089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular adhesion responses to the heparin-binding (HepII) domain of fibronectin require heparan sulfate with specific properties.
    Mahalingam Y; Gallagher JT; Couchman JR
    J Biol Chem; 2007 Feb; 282(5):3221-30. PubMed ID: 17130131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin and heparin binding domains of latent TGF-beta binding protein (LTBP)-4 mediate matrix targeting and cell adhesion.
    Kantola AK; Keski-Oja J; Koli K
    Exp Cell Res; 2008 Aug; 314(13):2488-500. PubMed ID: 18585707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural domains of heparan sulphate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII).
    Walker A; Gallagher JT
    Biochem J; 1996 Aug; 317 ( Pt 3)(Pt 3):871-7. PubMed ID: 8760376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel fibronectin binding site required for fibronectin fibril growth during matrix assembly.
    Sechler JL; Rao H; Cumiskey AM; Vega-Colón I; Smith MS; Murata T; Schwarzbauer JE
    J Cell Biol; 2001 Sep; 154(5):1081-8. PubMed ID: 11535624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of the fibrin-binding domain by β-strand addition is sufficient for expansion of soluble fibronectin.
    Maurer LM; Ma W; Eickstaedt NL; Johnson IA; Tomasini-Johansson BR; Annis DS; Mosher DF
    J Biol Chem; 2012 Apr; 287(16):13303-12. PubMed ID: 22351755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulatory roles for integrin activation and the synergy site of fibronectin during matrix assembly.
    Sechler JL; Corbett SA; Schwarzbauer JE
    Mol Biol Cell; 1997 Dec; 8(12):2563-73. PubMed ID: 9398676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
    Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
    Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated hyaluronan alters fibronectin matrix assembly and promotes osteogenic differentiation of human bone marrow stromal cells.
    Vogel S; Arnoldini S; Möller S; Schnabelrauch M; Hempel U
    Sci Rep; 2016 Nov; 6():36418. PubMed ID: 27808176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-dependent regulation of fibronectin matrix conformation.
    Hubbard B; Buczek-Thomas JA; Nugent MA; Smith ML
    Matrix Biol; 2014 Feb; 34():124-31. PubMed ID: 24148804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of integrin binding sites in fibronectin matrix assembly in vivo.
    Leiss M; Beckmann K; Girós A; Costell M; Fässler R
    Curr Opin Cell Biol; 2008 Oct; 20(5):502-7. PubMed ID: 18586094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly of fibronectin extracellular matrix.
    Singh P; Carraher C; Schwarzbauer JE
    Annu Rev Cell Dev Biol; 2010; 26():397-419. PubMed ID: 20690820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin.
    Bultmann H; Santas AJ; Peters DM
    J Biol Chem; 1998 Jan; 273(5):2601-9. PubMed ID: 9446562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
    Schousboe I; Nystrøm BT; Hansen GH
    FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced conformational changes of fibronectin within the extracellular matrix promote hMSC osteogenic differentiation.
    Li B; Lin Z; Mitsi M; Zhang Y; Vogel V
    Biomater Sci; 2015 Jan; 3(1):73-84. PubMed ID: 26214191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered rate of fibronectin matrix assembly by deletion of the first type III repeats.
    Sechler JL; Takada Y; Schwarzbauer JE
    J Cell Biol; 1996 Jul; 134(2):573-83. PubMed ID: 8707839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites.
    Mitsi M; Hong Z; Costello CE; Nugent MA
    Biochemistry; 2006 Aug; 45(34):10319-28. PubMed ID: 16922507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.